Status
Conditions
Treatments
About
This study aims to constitute a collection of biological materials from in transplant patients and to provide biological materials from transplanted patients in order :
i) validate new theory on the cause of allograft loss, ii) develop innovative biomarker for rejection and other transplantation-related conditions (such as BK virus nephropathy, Post-transplant lymphoproliferative disorder ( PTLD) ...)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Olivier Thaunat, MD; Emmanuel Morelon, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal